Study on the bioequivalence of zolpidem tartrate in healthy Chinese vol unteers

熊玉卿,姜敏,戴群
DOI: https://doi.org/10.3321/j.issn:1001-2494.2001.11.010
2001-01-01
Abstract:OBJECTIVE: A HPLC method with fluorescence detection was developed and validated to determine the concentrations of zolpidem in human plasma. To study the pharmacokinetics and bioequivalence of zolpidem in healthy Chinese volunteers. METHODS: Single dose of 10 mg of domestic or imported zolpidem was given to 20 healthy volunteers. The blood samples were withdrawn up to 24 hours post-administration, and the plasma concentrations of zolpidem were determined by HPLC method. RESULTS: The concentration-time curves of two preparations were fitted to a one-compartment open model with first-order absorption, first-order elimination from the central compartment. The main pharmacokinetic parameters of domestic or imported preparations were as follows: AUC 0-12 (532.7 ± 135.7) and (530.9 ± 136.5) μg·h·L -1 c max(134.2 ± 31.5) and (136.3 ± 35.3) μg·L -1, t max(1.05 ± 0.39) and (1.10 ± 0.45) h, t 1/2ke (2.34 ± 0.29) and (2.32 ± 0.21) h, respectively. There were no significant differences in the parameters of two preparations (P > 0.05). The relative bioavailability of domestic tablet of zolpidem was (101.2 ± 12.0) %. CONCLUSION: The results of statistical analysis showed that the two formulations were bioequivalent.
What problem does this paper attempt to address?